AI
Tuesday, August 21, 2012 1:22:26 PM
PPHM Sep 22 2012 2.5 Put
@0.45
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and infectious diseases. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara. (Take-over candidate?)
http://www.melodika.net/index.php?option=com_content&task=view&id=363236&Itemid=54
@0.45
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and infectious diseases. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara. (Take-over candidate?)
http://www.melodika.net/index.php?option=com_content&task=view&id=363236&Itemid=54
My post is for my entertainment, do your own DD before pushing your
buy/sell buttons
Unleash the power of Level 2
Spot liquidity moves with access to US order books.
